Sub menu

Table. Recommendations for meningococcal vaccines for healthy people aged ≥2 years, by age and vaccine brand

Age at start of vaccine course	Vaccine type	Vaccine brand	Dose requirements for healthy people (without any medical conditions associated with increased risk of invasive meningococcal disease)
2–9 years	MenACWY	Preferably Menveo or Nimenrix, otherwise Menactra	1 dose
2–9 years	MenB	Bexsero	2 doses (8 weeks between doses)
≥10 years	MenACWY^a	Preferably Menveo or Nimenrix, otherwise Menactra	1 dose
	MenB	Bexsero	2 doses (8 weeks between doses)
	MenB	Trumenba	2 doses (6 months between doses)
MenACWY^a- aThere is no registered upper age limit for use of Menveo and Nimenrix. Although Menactra is registered for use up to 55 years of age only, it can be given to people >55 years of age.

Page history

Last updated

5 June 2018

Last reviewed

5 June 2018

Printed content may be out of date. For up to date information, always refer to the digital version:

https://immunisationhandbook.health.gov.au/resources/tables/table-recommendations-for-meningococcal-vaccines-for-healthy-people-aged-2-years-by-age-and-vaccine-brand

Link, share or bookmark directly to this section of the page.